FDA Inspection 656254 — New Jersey Laboratories

New Jersey Laboratories — FEI 2219935

The FDA completed an inspection of New Jersey Laboratories on April 9, 2010 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 9, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Brunswick, NJ (United States)